Omizzur
Wuhan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A proteomics and peptide technology company providing custom synthesis and developing peptide-based diagnostics.
Infectious DiseaseOncology
Technology Platform
Advanced platform for custom peptide synthesis, modification, and purification, applied to reagent and diagnostic development.
Opportunities
Growing demand for high-quality peptides for research, diagnostics, and as starting materials for new therapeutics.
Risk Factors
Service-based revenue dependency and challenges in scaling its proprietary diagnostic products in a competitive market.
Competitive Landscape
Competes in the fragmented custom peptide synthesis market and niche diagnostic segments with larger life science tools companies.